Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity

OBJECTIVE: This study was conducted to determine whether increased body mass index (BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of hypothalamic-pituitary-ovarian (HPO) axis activity. STUDY DESIGN: Ovulatory reproductive-age women of normal (< 25 kg/m(2); n = 10) and obes...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Edelman, Alison B, Carlson, Nichole E, Cherala, Ganesh, Munar, Myrna Y., Stouffer, Richard L, Cameron, Judy L, Stanczyk, Frank Z., Jensen, Jeffrey T
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2736633/
https://ncbi.nlm.nih.gov/pubmed/19631786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2009.04.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky